{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:26:54Z","timestamp":1790324814135,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["213145\/HO-20-20025"],"award-info":[{"award-number":["213145\/HO-20-20025"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.anai.2021.05.021","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T08:33:39Z","timestamp":1621845219000},"page":"354-362.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities"],"prefix":"10.1016","volume":"127","author":[{"given":"Thomas","family":"Casale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor A.","family":"Molfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bogart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Packnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2021.05.021_bib0001","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2021.05.021_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/JAA.S236609","article-title":"Real-world effectiveness of mepolizumab in patients with severe asthma: an examination of exacerbations and costs","volume":"13","author":"Llanos","year":"2020","journal-title":"J Asthma Allergy"},{"issue":"4","key":"10.1016\/j.anai.2021.05.021_bib0003","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma worldwide: data from the international severe asthma registry","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"issue":"S2","key":"10.1016\/j.anai.2021.05.021_bib0004","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.5694\/mja18.00196","article-title":"Managing comorbid conditions in severe asthma","volume":"209","author":"Bardin","year":"2018","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.anai.2021.05.021_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2500\/aap.2020.41.200043","article-title":"Impact of mepolizumab on exacerbations in severe asthma: results from a U.S. insurance claims data base","volume":"41","author":"Ortega","year":"2020","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0006","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41533-017-0026-x","article-title":"High probability of comorbidities in bronchial asthma in Germany","volume":"27","author":"Heck","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"issue":"3","key":"10.1016\/j.anai.2021.05.021_bib0007","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/02770900600566405","article-title":"Tenor Study Group. Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: outcomes and Treatment Regimens (TENOR) study","volume":"43","author":"Lee","year":"2006","journal-title":"J Asthma"},{"issue":"3","key":"10.1016\/j.anai.2021.05.021_bib0008","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12016-015-8503-x","article-title":"The epidemiology of anaphylaxis","volume":"54","author":"Yu","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.anai.2021.05.021_bib0009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JAA.S150462","article-title":"Is it severe asthma or asthma with severe comorbidities?","volume":"10","author":"Brussino","year":"2017","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.anai.2021.05.021_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40733-015-0008-0","article-title":"Allergic rhinitis: the \u201cGhost Diagnosis\u201d in patients with asthma","volume":"1","author":"Egan","year":"2015","journal-title":"Asthma Res Pract"},{"issue":"2","key":"10.1016\/j.anai.2021.05.021_bib0011","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1378\/chest.130.2.429","article-title":"Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function","volume":"130","author":"Dixon","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.anai.2021.05.021_bib0012","first-page":"45","article-title":"Nasal polyps in patients with asthma: prevalence, impact, and management challenges","volume":"9","author":"Langdon","year":"2016","journal-title":"J Asthma Allergy"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2500\/ajra.2016.30.4252","article-title":"Relationships among allergic rhinitis, asthma, and chronic rhinosinusitis","volume":"30","author":"Rosati","year":"2016","journal-title":"Am J Rhinol Allergy"},{"issue":"suppl 1","key":"10.1016\/j.anai.2021.05.021_bib0014","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2466-6-S1-S3","article-title":"Survey on the impact of comorbid allergic rhinitis in patients with asthma","volume":"6","author":"Valovirta","year":"2006","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1016\/j.anai.2021.05.021_bib0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-2600(18)30100-0","article-title":"Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life","volume":"6","author":"Bui","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.anai.2021.05.021_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pupt.2018.08.006","article-title":"Asthma COPD overlap: impact of associated comorbidities","volume":"52","author":"Maselli","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0017","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/ers.09.60","article-title":"Role of infection in the development and exacerbation of asthma","volume":"4","author":"Guilbert","year":"2010","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"10.1016\/j.anai.2021.05.021_bib0018","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1183\/09031936.00046013","article-title":"Metabolic syndrome and incidence of asthma in adults: the HUNT study","volume":"42","author":"Brumpton","year":"2013","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.anai.2021.05.021_bib0019","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2222.2008.03197.x","article-title":"Insulin resistance as a predictor of incident asthma-like symptoms in adults","volume":"39","author":"Thuesen","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2021.05.021_bib0020","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1164\/rccm.201905-1071ST","article-title":"Evaluation and management of obesity hypoventilation syndrome. An official American Thoracic Society clinical practice guideline","volume":"200","author":"Mokhlesi","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2021.05.021_bib0021","doi-asserted-by":"crossref","first-page":"e61022","DOI":"10.1371\/journal.pone.0061022","article-title":"Physical deconditioning as a cause of breathlessness among obese adolescents with a diagnosis of asthma","volume":"8","author":"Shim","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.anai.2021.05.021_bib0022","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaip.2015.11.013","article-title":"Corticosteroid pharmacokinetic abnormalities in overweight and obese corticosteroid resistant asthmatics","volume":"4","author":"Goleva","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2021.05.021_bib0023","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2018.02.004","article-title":"Obesity and asthma","volume":"141","author":"Peters","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.05.021_bib0024","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2018.01.026","article-title":"Factors reducing omalizumab response in severe asthma","volume":"52","author":"Sposato","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/S1806-37132011000100004","article-title":"Anxiety and depression in asthma patients: impact on asthma control","volume":"37","author":"Vieira","year":"2011","journal-title":"J Bras Pneumol"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0026","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anai.2018.03.024","article-title":"Barriers to medication adherence in asthma: the importance of culture and context","volume":"121","author":"McQuaid","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2021.05.021_bib0027","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11606-016-3968-8","article-title":"The high and rising costs of obesity to the US health care system","volume":"32","author":"Biener","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.anai.2021.05.021_bib0028","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1183\/13993003.01141-2016","article-title":"Excess medical costs in patients with asthma and the role of comorbidity","volume":"48","author":"Chen","year":"2016","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.anai.2021.05.021_bib0029","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/thoraxjnl-2019-213223","article-title":"Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study","volume":"74","author":"Chen","year":"2019","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.anai.2021.05.021_bib0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.15252\/embr.201642951","article-title":"The economic costs of mental disorders: do our societies react appropriately to the burden of mental disorders?","volume":"17","author":"Trautmann","year":"2016","journal-title":"EMBO Rep"},{"issue":"3","key":"10.1016\/j.anai.2021.05.021_bib0031","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1183\/13993003.00188-2015","article-title":"Trends and predictors of asthma costs: results from a 10-year longitudinal study","volume":"47","author":"Tan","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.anai.2021.05.021_bib0032","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/02770901003801980","article-title":"Obesity and asthma morbidity in a community-based adult cohort in a large urban area: the Chicago Initiative to Raise Asthma Health Equity (CHIRAH)","volume":"47","author":"Grammer","year":"2010","journal-title":"J Asthma"},{"key":"10.1016\/j.anai.2021.05.021_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618808490","article-title":"Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience","volume":"12","author":"Emma","year":"2018","journal-title":"Ther Adv Respir Dis"},{"issue":"13","key":"10.1016\/j.anai.2021.05.021_bib0034","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.anai.2021.05.021_bib0035","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"issue":"9842","key":"10.1016\/j.anai.2021.05.021_bib0036","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.anai.2021.05.021_bib0037","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(17)30125-X","article-title":"Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial","volume":"5","author":"Chupp","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.anai.2021.05.021_bib0038","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jaci.2016.08.008","article-title":"Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma","volume":"139","author":"Yancey","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2021.05.021_bib0039","doi-asserted-by":"crossref","first-page":"AB94","DOI":"10.1016\/j.jaci.2018.12.286","article-title":"Mepolizumab improves patient outcomes and reduces exacerbations in severe asthma patients with comorbid upper airways disease","volume":"143","author":"Prazma","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.05.021_bib0040","first-page":"OA2104","article-title":"Late Breaking Abstract - effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study","volume":"54","author":"Harrison","year":"2019","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.anai.2021.05.021_bib0041","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02345-2019","article-title":"Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme","volume":"55","author":"Taill\u00e9","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.anai.2021.05.021_bib0042","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaip.2017.12.019","article-title":"Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma","volume":"6","author":"Ortega","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0043","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.anai.2021.05.021_bib0044","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention.Available at: https:\/\/ginasthma.org\/wp-content\/uploads\/2020\/04\/GINA-2020-full-report_-final-_wms.pdf. Accessed September 12, 2020."},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MCP.0b013e328341005f","article-title":"Anxiety and depression in asthma","volume":"17","author":"Di Marco","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.anai.2021.05.021_bib0046","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaip.2013.07.009","article-title":"Overweight\/obesity and risk of seasonal asthma exacerbations","volume":"1","author":"Schatz","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2021.05.021_bib0047","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaci.2015.07.046","article-title":"Acute and chronic systemic corticosteroid-related complications in patients with severe asthma","volume":"136","author":"Lefebvre","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.05.021_bib0048","unstructured":"Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD COPD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: https:\/\/goldcopd.org\/wp-content\/uploads\/2019\/12\/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed July 16, 2020."},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0049","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12931-021-01746-4","article-title":"Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions","volume":"22","author":"Gibson","year":"2021","journal-title":"J Respir Res"},{"key":"10.1016\/j.anai.2021.05.021_bib0050","first-page":"4616","article-title":"Late breaking abstract - add-on mepolizumab for chronic rhinosinusitis with nasal polyps: SYNAPSE study","volume":"56","author":"Hopkins","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0051","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-019-1134-7","article-title":"Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight\/body mass index: meta-analysis of MENSA and MUSCA","volume":"20","author":"Albers","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.anai.2021.05.021_bib0052","doi-asserted-by":"crossref","unstructured":"Bedolla-Barajas M, Morales-Romero J, Fonseca-L\u00f3pez JC, Pulido-Guill\u00e9n NA, Larenas-Linnemann D, Hern\u00e1ndez-Col\u00edn DD. Anxiety and depression in adult patients with asthma: the role of asthma control, obesity and allergic sensitization [e-pub ahead of print]. J Asthma. https:\/\/doi.org\/10.1080\/02770903.2020.1759087, accessed June 11, 2021.","DOI":"10.1080\/02770903.2020.1759087"},{"key":"10.1016\/j.anai.2021.05.021_bib0053","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1745-0179-1-18","article-title":"Asthma and depression: a pragmatic review of the literature and recommendations for future research","volume":"1","author":"Opolski","year":"2005","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"1","key":"10.1016\/j.anai.2021.05.021_bib0054","doi-asserted-by":"crossref","first-page":"16107","DOI":"10.1038\/s41598-019-52361-9","article-title":"Effect of asthma control on general health-related quality of life in patients diagnosed with adult-onset asthma","volume":"9","author":"Ilmarinen","year":"2019","journal-title":"Sci Rep"},{"issue":"suppl 86","key":"10.1016\/j.anai.2021.05.021_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and allergen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621003823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621003823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:27:27Z","timestamp":1761053247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621003823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1081120621003823"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.05.021","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}